New opportunities: Harnessing induced pluripotency for discovery in diabetes and metabolism

Cell Metabolism

Volumn 18, Issue 6, 2013, Pages 775-791

  Teo, Adrian Kee Keong ^a   Wagers, Amy J ^a,b,c   Kulkarni, Rohit N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Harvard University   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AGOUTI RELATED PROTEIN; ALLOXAN; ALPHA INTERMEDIN; ANTIDIABETIC AGENT; BETA INTERMEDIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME; FATTY ACID BINDING PROTEIN 2; G PROTEIN COUPLED RECEPTOR; GLUCAGON RECEPTOR; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; GLYCOGEN SYNTHASE; GLYCOSYLATED HEMOGLOBIN; HISTOCOMPATIBILITY ANTIGEN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; LEPTIN RECEPTOR; MC 4R PROTEIN; MITOCHONDRIAL DNA; NEUROGENIC DIFFERENTIATION FACTOR; NEUROPEPTIDE Y; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROHORMONE CONVERTASE 1; PROINSULIN; PROOPIOMELANOCORTIN; STREPTOZOCIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACANTHOSIS NIGRICANS; ADIPOCYTE; AEROBIC METABOLISM; AGENESIS; ALPHA 1 ANTITRYPSIN DEFICIENCY; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; APPETITE; AUTOSOMAL DOMINANT INHERITANCE; B LYMPHOCYTE; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; DEATH; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC FOOT; DIABETIC FOOT ULCER; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE PREDISPOSITION; DYSAUTONOMIA; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; EXERCISE; EXERCISE PHYSIOLOGY; EXTRACELLULAR MATRIX; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL PARTIAL LIPODYSTROPHY; FANCONI ANEMIA; FIBROBLAST; FRAMESHIFT MUTATION; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE SENSOR; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; GROWTH RETARDATION; HAPLOINSUFFICIENCY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; HETEROZYGOTE; HUMAN; HYPERANDROGENISM; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGLYCEMIA; HYPOTHALAMUS; IMMUNOLOGICAL TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; INSULIN TREATMENT; KERATINOCYTE; KETOACIDOSIS; KIDNEY CELL; KIDNEY DISEASE; KIDNEY FAILURE; LACTIC ACIDOSIS; LASER SURGERY; LEOPARD SYNDROME; LEPRECHAUNISM; LEPTIN DEFICIENCY; LIPID STORAGE; LIPID TRANSPORT; LIPOATROPHIC DIABETES MELLITUS; LIVER CELL; LIVER FUNCTION; LONG QT SYNDROME; LOSS OF FUNCTION MUTATION; MATERNALLY INHERITED DIABETES AND DEAFNESS; MELAS SYNDROME; MESENCHYMAL STROMA CELL; METABOLIC SYNDROME X; MICROBIOME; MITOCHONDRIAL ENCEPHALOPATHY; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYOBLAST; NEOVASCULARIZATION (PATHOLOGY); NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR REPROGRAMMING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; OXIDATIVE PHOSPHORYLATION; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS RESECTION; PARKINSON DISEASE; PATHOGENESIS; PERCEPTION DEAFNESS; PERIPHERAL NEUROPATHY; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGERIA; PROTEIN SYNTHESIS; PROTO ONCOGENE; QT PROLONGATION; RECANALIZATION; RETINA DETACHMENT; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETINOPATHY; RETT SYNDROME; REVIEW; RISK FACTOR; SATIETY; SCHIZOPHRENIA; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SKIN CELL; SKIN FIBROBLAST; SPINAL MUSCULAR ATROPHY; STEM CELL; STIMULUS SECRETION COUPLING; VARIABLE NUMBER OF TANDEM REPEAT; VASCULAR DISEASE; VIRUS INFECTION; VITREOUS HEMORRHAGE; WOUND HEALING;

ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INSULIN RESISTANCE; METABOLIC SYNDROME X;

EID: 84889651423     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.08.010     Document Type: Review

References (178)

1. M. Abbate, P. Cravedi, I. Iliev, G. Remuzzi, and P. Ruggenenti Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives Curr. Diabetes Rev. 7 2011 190 200
2. L. Aguilar-Bryan, and J. Bryan Neonatal diabetes mellitus Endocr. Rev. 29 2008 265 291
3. A. Aleixandre de Artiñano, and M. Miguel Castro Experimental rat models to study the metabolic syndrome Br. J. Nutr. 102 2009 1246 1253
4. C.E. Alpers, and K.L. Hudkins Mouse models of diabetic nephropathy Curr. Opin. Nephrol. Hypertens. 20 2011 278 284
5. H. Andersen Motor dysfunction in diabetes Diabetes Metab. Res. Rev. 28 Suppl 1 2012 89 92
6. D.A. Antonetti, R. Klein, and T.W. Gardner Diabetic retinopathy N. Engl. J. Med. 366 2012 1227 1239
7. L. Armstrong, O. Hughes, S. Yung, L. Hyslop, R. Stewart, I. Wappler, H. Peters, T. Walter, P. Stojkovic, and J. Evans The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis Hum. Mol. Genet. 15 2006 1894 1913
8. P.R. Baker II, and A.K. Steck The past, present, and future of genetic associations in type 1 diabetes Curr. Diab. Rep. 11 2011 445 453
9. O. Bar-Nur, H.A. Russ, S. Efrat, and N. Benvenisty Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells Cell Stem Cell 9 2011 17 23
10. A. Barker, C. Langenberg, and N.J. Wareham Genetic determinants of glucose homeostasis Best Pract. Res. Clin. Endocrinol. Metab. 26 2012 159 170
11. C.A. Batchelder, C.C. Lee, D.G. Matsell, M.C. Yoder, and A.F. Tarantal Renal ontogeny in the rhesus monkey (Macaca mulatta) and directed differentiation of human embryonic stem cells towards kidney precursors Differentiation 78 2009 45 56
12. M. Bellin, M.C. Marchetto, F.H. Gage, and C.L. Mummery Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol. 13 2012 713 726
13. S.C. Bendall, M.H. Stewart, P. Menendez, D. George, K. Vijayaragavan, T. Werbowetski-Ogilvie, V. Ramos-Mejia, A. Rouleau, J. Yang, and M. Bossé IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro Nature 448 2007 1015 1021
14. B. Binétruy, L. Heasley, F. Bost, L. Caron, and M. Aouadi Concise review: regulation of embryonic stem cell lineage commitment by mitogen-activated protein kinases Stem Cells 25 2007 1090 1095
15. C. Bingham, M.P. Bulman, S. Ellard, L.I. Allen, G.W. Lipkin, W.G. Hoff, A.S. Woolf, G. Rizzoni, G. Novelli, A.J. Nicholls, and A.T. Hattersley Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease Am. J. Hum. Genet. 68 2001 219 224
16. L. Bjørkhaug, J.V. Sagen, P. Thorsby, O. Søvik, A. Molven, and P.R. Njølstad Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway J. Clin. Endocrinol. Metab. 88 2003 920 931
17. K.E. Bornfeldt, and I. Tabas Insulin resistance, hyperglycemia, and atherosclerosis Cell Metab. 14 2011 575 585
18. M. Borowiec, C.W. Liew, R. Thompson, W. Boonyasrisawat, J. Hu, W.M. Mlynarski, I. El Khattabi, S.H. Kim, L. Marselli, and S.S. Rich Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction Proc. Natl. Acad. Sci. USA 106 2009 14460 14465
19. G.L. Boulting, E. Kiskinis, G.F. Croft, M.W. Amoroso, D.H. Oakley, B.J. Wainger, D.J. Williams, D.J. Kahler, M. Yamaki, and L. Davidow A functionally characterized test set of human induced pluripotent stem cells Nat. Biotechnol. 29 2011 279 286
20. F.C. Brosius III, C.E. Alpers, E.P. Bottinger, M.D. Breyer, T.M. Coffman, S.B. Gurley, R.C. Harris, M. Kakoki, M. Kretzler, E.H. Leiter Animal Models of Diabetic Complications Consortium Mouse models of diabetic nephropathy J. Am. Soc. Nephrol. 20 2009 2503 2512
21. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
22. H. Bugger, and E.D. Abel Rodent models of diabetic cardiomyopathy Dis. Model. Mech. 2 2009 454 466
23. M.M. Byrne, J. Sturis, S.S. Fajans, F.J. Ortiz, A. Stoltz, M. Stoffel, M.J. Smith, G.I. Bell, J.B. Halter, and K.S. Polonsky Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20 Diabetes 44 1995 699 704
24. J.M. Campbell, M.B. Nottle, I. Vassiliev, M. Mitchell, and M. Lane Insulin increases epiblast cell number of in vitro cultured mouse embryos via the PI3K/GSK3/p53 pathway Stem Cells Dev. 21 2012 2430 2441
25. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
26. C.W. Chang, Y.S. Lai, K.M. Pawlik, K. Liu, C.W. Sun, C. Li, T.R. Schoeb, and T.M. Townes Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells Stem Cells 27 2009 1042 1049
27. G. Chen, D.R. Gulbranson, Z. Hou, J.M. Bolin, V. Ruotti, M.D. Probasco, K. Smuga-Otto, S.E. Howden, N.R. Diol, and N.E. Propson Chemically defined conditions for human iPSC derivation and culture Nat. Methods 8 2011 424 429
28. X. Cheng, L. Ying, L. Lu, A.M. Galvão, J.A. Mills, H.C. Lin, D.N. Kotton, S.S. Shen, M.C. Nostro, and J.K. Choi Self-renewing endodermal progenitor lines generated from human pluripotent stem cells Cell Stem Cell 10 2012 371 384
29. K. Clément, C. Vaisse, N. Lahlou, S. Cabrol, V. Pelloux, D. Cassuto, M. Gourmelen, C. Dina, J. Chambaz, and J.M. Lacorte A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction Nature 392 1998 398 401
30. A.R. Clocquet, J.M. Egan, D.A. Stoffers, D.C. Muller, L. Wideman, G.A. Chin, W.L. Clarke, J.B. Hanks, J.F. Habener, and D. Elahi Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene) Diabetes 49 2000 1856 1864
31. F.S. Collins, and M.K. Mansoura The Human Genome Project. Revealing the shared inheritance of all humankind Cancer 91 Suppl 2001 221 225
32. P. Collombat, J. Hecksher-Sørensen, V. Broccoli, J. Krull, I. Ponte, T. Mundiger, J. Smith, P. Gruss, P. Serup, and A. Mansouri The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas Development 132 2005 2969 2980
33. K.T. Coppieters, A. Wiberg, S.M. Tracy, and M.G. von Herrath Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma Clin. Exp. Immunol. 168 2012 5 11
34. E.A. Craig, M.V. Stevens, R.R. Vaillancourt, and T.D. Camenisch MAP3Ks as central regulators of cell fate during development Dev. Dyn. 237 2008 3102 3114
35. J.E. Davies, M. Siczkowski, F.P. Sweeney, P.A. Quinn, B. Krolewski, A.S. Krolewski, and L.L. Ng Glucose-induced changes in turnover of Na+/H+ exchanger of immortalized lymphoblasts from type I diabetic patients with nephropathy Diabetes 44 1995 382 388
36. R. Dhingra, and R.S. Vasan Diabetes and the risk of heart failure Heart Fail. Clin. 8 2012 125 133
37. Q. Ding, Y.K. Lee, E.A. Schaefer, D.T. Peters, A. Veres, K. Kim, N. Kuperwasser, D.L. Motola, T.B. Meissner, and W.T. Hendriks A TALEN genome-editing system for generating human stem cell-based disease models Cell Stem Cell 12 2013 238 251
38. Q. Ding, S.N. Regan, Y. Xia, L.A. Oostrom, C.A. Cowan, and K. Musunuru Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs Cell Stem Cell 12 2013 393 394
39. A. Doria, M.E. Patti, and C.R. Kahn The emerging genetic architecture of type 2 diabetes Cell Metab. 8 2008 186 200
40. J.P. Driver, D.V. Serreze, and Y.G. Chen Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease Semin. Immunopathol. 33 2011 67 87
41. S.M. Dymecki, J.E. Niederhuber, and S.V. Desiderio Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells Science 247 1990 332 336
42. A.D. Ebert, J. Yu, F.F. Rose Jr., V.B. Mattis, C.L. Lorson, J.A. Thomson, and C.N. Svendsen Induced pluripotent stem cells from a spinal muscular atrophy patient Nature 457 2009 277 280
43. E.L. Edghill, S.E. Flanagan, and S. Ellard Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11 Rev. Endocr. Metab. Disord. 11 2010 193 198
44. L. Eiselleova, K. Matulka, V. Kriz, M. Kunova, Z. Schmidtova, J. Neradil, B. Tichy, D. Dvorakova, S. Pospisilova, A. Hampl, and P. Dvorak A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells Stem Cells 27 2009 1847 1857
45. S. Erceg, M. Ronaghi, and M. Stojković Human embryonic stem cell differentiation toward regional specific neural precursors Stem Cells 27 2009 78 87
46. S.S. Fajans, G.I. Bell, and K.S. Polonsky Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young N. Engl. J. Med. 345 2001 971 980
47. I.S. Farooqi, J.M. Keogh, G.S. Yeo, E.J. Lank, T. Cheetham, and S. O'Rahilly Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene N. Engl. J. Med. 348 2003 1085 1095
48. M.E. Fernandez-Zapico, J.C. van Velkinburgh, R. Gutiérrez-Aguilar, B. Neve, P. Froguel, R. Urrutia, and R. Stein MODY7 gene, KLF11, is a novel p300-dependent regulator of Pdx-1 (MODY4) transcription in pancreatic islet beta cells J. Biol. Chem. 284 2009 36482 36490
49. J. Ferrer A genetic switch in pancreatic beta-cells: implications for differentiation and haploinsufficiency Diabetes 51 2002 2355 2362
50. P.W. Franks Gene × environment interactions in type 2 diabetes Curr. Diab. Rep. 11 2011 552 561
51. P. Froguel, H. Zouali, N. Vionnet, G. Velho, M. Vaxillaire, F. Sun, S. Lesage, M. Stoffel, J. Takeda, and P. Passa Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus N. Engl. J. Med. 328 1993 697 702
52. J. Fujikura, K. Nakao, M. Sone, M. Noguchi, E. Mori, M. Naito, D. Taura, M. Harada-Shiba, I. Kishimoto, and A. Watanabe Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation Diabetologia 55 2012 1689 1698
53. S. Ghosh, S. Golbidi, I. Werner, B.C. Verchere, and I. Laher Selecting exercise regimens and strains to modify obesity and diabetes in rodents: an overview Clin. Sci. 119 2010 57 74
54. F. González, S. Boué, and J.C. Izpisúa Belmonte Methods for making induced pluripotent stem cells: reprogramming à la carte Nat. Rev. Genet. 12 2011 231 242
55. P.A. Gruppuso, P. Gorden, C.R. Kahn, M. Cornblath, W.P. Zeller, and R. Schwartz Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin N. Engl. J. Med. 311 1984 629 634
56. I.S. Haldorsen, M. Vesterhus, H. Raeder, D.K. Jensen, O. Søvik, A. Molven, and P.R. Njølstad Lack of pancreatic body and tail in HNF1B mutation carriers Diabet. Med. 25 2008 782 787
57. D. Hambright, K.Y. Park, M. Brooks, R. McKay, A. Swaroop, and I.O. Nasonkin Long-term survival and differentiation of retinal neurons derived from human embryonic stem cell lines in un-immunosuppressed mouse retina Mol. Vis. 18 2012 920 936
58. H.J. Harwood Jr., P. Listrani, and J.D. Wagner Nonhuman primates and other animal models in diabetes research J. Diabetes Sci. Tech. 6 2012 503 514
59. A.T. Hattersley, and F.M. Ashcroft Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy Diabetes 54 2005 2503 2513
60. C. Haumaitre, E. Barbacci, M. Jenny, M.O. Ott, G. Gradwohl, and S. Cereghini Lack of TCF2/vHNF1 in mice leads to pancreas agenesis Proc. Natl. Acad. Sci. USA 102 2005 1490 1495
61. G.P. Hayhurst, Y.H. Lee, G. Lambert, J.M. Ward, and F.J. Gonzalez Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis Mol. Cell. Biol. 21 2001 1393 1403
62. R.A. Hegele Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome Trends Endocrinol. Metab. 14 2003 371 377
63. Y. Horikawa, N. Iwasaki, M. Hara, H. Furuta, Y. Hinokio, B.N. Cockburn, T. Lindner, K. Yamagata, M. Ogata, and O. Tomonaga Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY Nat. Genet. 17 1997 384 385
64. H. Hua, L. Shang, H. Martinez, M. Freeby, M.P. Gallagher, T. Ludwig, L. Deng, E. Greenberg, C. Leduc, and W.K. Chung iPSC-derived β cells model diabetes due to glucokinase deficiency J. Clin. Invest. 123 2013 3146 3153
65. L.L. Ilag, B.P. Tabaei, W.H. Herman, C.M. Zawacki, E. D'Souza, G.I. Bell, and S.S. Fajans Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene Diabetes 49 2000 961 968
66. M.S. Islam, and T. Loots Experimental rodent models of type 2 diabetes: a review Methods Find. Exp. Clin. Pharmacol. 31 2009 249 261
67. B. Isomaa, M. Henricsson, M. Lehto, C. Forsblom, S. Karanko, L. Sarelin, M. Häggblom, and L. Groop Chronic diabetic complications in patients with MODY3 diabetes Diabetologia 41 1998 467 473
68. I. Itzhaki, L. Maizels, I. Huber, L. Zwi-Dantsis, O. Caspi, A. Winterstern, O. Feldman, A. Gepstein, G. Arbel, and H. Hammerman Modelling the long QT syndrome with induced pluripotent stem cells Nature 471 2011 225 229
69. P.B. Iynedjian, P.R. Pilot, T. Nouspikel, J.L. Milburn, C. Quaade, S. Hughes, C. Ucla, and C.B. Newgard Differential expression and regulation of the glucokinase gene in liver and islets of Langerhans Proc. Natl. Acad. Sci. USA 86 1989 7838 7842
70. R.S. Jackson, J.W. Creemers, S. Ohagi, M.L. Raffin-Sanson, L. Sanders, C.T. Montague, J.C. Hutton, and S. O'Rahilly Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene Nat. Genet. 16 1997 303 306
71. J. Jonsson, L. Carlsson, T. Edlund, and H. Edlund Insulin-promoter-factor 1 is required for pancreas development in mice Nature 371 1994 606 609
72. C.R. Kahn Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes Diabetes 43 1994 1066 1084
73. C.R. Kahn, D. Vicent, and A. Doria Genetics of non-insulin-dependent (type-II) diabetes mellitus Annu. Rev. Med. 47 1996 509 531
74. P. Kannankeril, D.M. Roden, and D. Darbar Drug-induced long QT syndrome Pharmacol. Rev. 62 2010 760 781
75. Y. Keshet, and R. Seger The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions Methods Mol. Biol. 661 2010 3 38
76. Y. Kida, and J.S. Duffield Pivotal role of pericytes in kidney fibrosis Clin. Exp. Pharmacol. Physiol. 38 2011 467 473
77. M.S. Kim, N.S. Hwang, J. Lee, T.K. Kim, K. Leong, M.J. Shamblott, J. Gearhart, and J. Elisseeff Musculoskeletal differentiation of cells derived from human embryonic germ cells Stem Cells 23 2005 113 123
78. A.J. King The use of animal models in diabetes research Br. J. Pharmacol. 166 2012 877 894
79. M. King, T. Pearson, A.A. Rossini, L.D. Shultz, and D.L. Greiner Humanized mice for the study of type 1 diabetes and beta cell function Ann. N Y Acad. Sci. 1150 2008 46 53
80. E. Kroon, L.A. Martinson, K. Kadoya, A.G. Bang, O.G. Kelly, S. Eliazer, H. Young, M. Richardson, N.G. Smart, and J. Cunningham Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo Nat. Biotechnol. 26 2008 443 452
81. H. Krude, H. Biebermann, W. Luck, R. Horn, G. Brabant, and A. Grüters Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans Nat. Genet. 19 1998 155 157
82. Y.C. Kudva, S. Ohmine, L.V. Greder, J.R. Dutton, A. Armstrong, J.G. De Lamo, Y.K. Khan, T. Thatava, M. Hasegawa, and N. Fusaki Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes Stem Cells Transl Med 1 2012 451 461
83. R.N. Kulkarni, and A. Zisman Lessons for human diabetes from experimental mouse models Curr. Diab. Rep. 3 2003 168 175
84. A.W. Lee, and R.D. Cox Use of mouse models in studying type 2 diabetes mellitus Expert Rev. Mol. Med. 13 2011 e1
85. G. Lee, E.P. Papapetrou, H. Kim, S.M. Chambers, M.J. Tomishima, C.A. Fasano, Y.M. Ganat, J. Menon, F. Shimizu, and A. Viale Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs Nature 461 2009 402 406
86. J. Li, G. Wang, C. Wang, Y. Zhao, H. Zhang, Z. Tan, Z. Song, M. Ding, and H. Deng MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal Differentiation 75 2007 299 307
87. L. Li, M. Fukunaga-Kalabis, and M. Herlyn The three-dimensional human skin reconstruct model: a tool to study normal skin and melanoma progression J. Vis. Exp. 54 2011 10.3791/2937
88. S.A. Lin, G. Kolle, S.M. Grimmond, Q. Zhou, E. Doust, M.H. Little, B. Aronow, S.D. Ricardo, M.F. Pera, J.F. Bertram, and A.L. Laslett Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors Stem Cells Dev. 19 2010 1637 1648
89. M.J. Luitse, G.J. Biessels, G.E. Rutten, and L.J. Kappelle Diabetes, hyperglycaemia, and acute ischaemic stroke Lancet Neurol. 11 2012 261 271
90. J.A. Maassen, G.M. Janssen, and L.M. 't Hart Molecular mechanisms of mitochondrial diabetes (MIDD) Ann. Med. 37 2005 213 221
91. D.J. Mackay, and I.K. Temple Transient neonatal diabetes mellitus type 1 Am. J. Med. Genet. C. Semin. Med. Genet. 154C 2010 335 342
92. R. Maehr, S. Chen, M. Snitow, T. Ludwig, L. Yagasaki, R. Goland, R.L. Leibel, and D.A. Melton Generation of pluripotent stem cells from patients with type 1 diabetes Proc. Natl. Acad. Sci. USA 106 2009 15768 15773
93. J. Magré, M. Delépine, E. Khallouf, T. Gedde-Dahl Jr., L. Van Maldergem, E. Sobel, J. Papp, M. Meier, A. Mégarbané, A. Bachy BSCL Working Group Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13 Nat. Genet. 28 2001 365 370
94. M.T. Malecki, U.S. Jhala, A. Antonellis, L. Fields, A. Doria, T. Orban, M. Saad, J.H. Warram, M. Montminy, and A.S. Krolewski Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus Nat. Genet. 23 1999 323 328
95. B.C. Martin, J.H. Warram, A.S. Krolewski, R.N. Bergman, J.S. Soeldner, and C.R. Kahn Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study Lancet 340 1992 925 929
96. D. Mathis, and C. Benoist The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding Immunol. Rev. 245 2012 239 249
97. F.M. Matschinsky, B. Glaser, and M.A. Magnuson Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities Diabetes 47 1998 307 315
98. M.I. McCarthy Genomics, type 2 diabetes, and obesity N. Engl. J. Med. 363 2010 2339 2350
99. A.B. McLean, K.A. D'Amour, K.L. Jones, M. Krishnamoorthy, M.J. Kulik, D.M. Reynolds, A.M. Sheppard, H. Liu, Y. Xu, E.E. Baetge, and S. Dalton Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed Stem Cells 25 2007 29 38
100. D.B. Mendel, L.P. Hansen, M.K. Graves, P.B. Conley, and G.R. Crabtree HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro Genes Dev. 5 1991 1042 1056
101. F.T. Merkle, and K. Eggan Modeling human disease with pluripotent stem cells: from genome association to function Cell Stem Cell 12 2013 656 668
102. S.P. Miller, G.R. Anand, E.J. Karschnia, G.I. Bell, D.C. LaPorte, and A.J. Lange Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype Diabetes 48 1999 1645 1651
103. R. Millioni, L. Puricelli, E. Iori, R. Trevisan, and P. Tessari Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population Diabetes Metab. Res. Rev. 28 2012 62 70
104. A. Molven, M. Ringdal, A.M. Nordbø, H. Raeder, J. Støy, G.M. Lipkind, D.F. Steiner, L.H. Philipson, I. Bergmann, D. Aarskog Norwegian Childhood Diabetes Study Group Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes Diabetes 57 2008 1131 1135
105. C.T. Montague, I.S. Farooqi, J.P. Whitehead, M.A. Soos, H. Rau, N.J. Wareham, C.P. Sewter, J.E. Digby, S.N. Mohammed, and J.A. Hurst Congenital leptin deficiency is associated with severe early-onset obesity in humans Nature 387 1997 903 908
106. A. Moretti, M. Bellin, A. Welling, C.B. Jung, J.T. Lam, L. Bott-Flügel, T. Dorn, A. Goedel, C. Höhnke, and F. Hofmann Patient-specific induced pluripotent stem-cell models for long-QT syndrome N. Engl. J. Med. 363 2010 1397 1409
107. C.E. Murry, and G. Keller Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development Cell 132 2008 661 680
108. K. Narayanan, K.M. Schumacher, F. Tasnim, K. Kandasamy, A. Schumacher, M. Ni, S. Gao, B. Gopalan, D. Zink, and J.Y. Ying Human embryonic stem cells differentiate into functional renal proximal tubular-like cells Kidney Int. 83 2013 593 603
109. F.J. Naya, H.P. Huang, Y. Qiu, H. Mutoh, F.J. DeMayo, A.B. Leiter, and M.J. Tsai Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice Genes Dev. 11 1997 2323 2334
110. B. Neve, M.E. Fernandez-Zapico, V. Ashkenazi-Katalan, C. Dina, Y.H. Hamid, E. Joly, E. Vaillant, Y. Benmezroua, E. Durand, and N. Bakaher Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function Proc. Natl. Acad. Sci. USA 102 2005 4807 4812
111. P.R. Njølstad, O. Søvik, A. Cuesta-Muñoz, L. Bjørkhaug, O. Massa, F. Barbetti, D.E. Undlien, C. Shiota, M.A. Magnuson, and A. Molven Neonatal diabetes mellitus due to complete glucokinase deficiency N. Engl. J. Med. 344 2001 1588 1592
112. D.T. Odom, R.D. Dowell, E.S. Jacobsen, W. Gordon, T.W. Danford, K.D. MacIsaac, P.A. Rolfe, C.M. Conboy, D.K. Gifford, and E. Fraenkel Tissue-specific transcriptional regulation has diverged significantly between human and mouse Nat. Genet. 39 2007 730 732
113. S. Ohmine, K.A. Squillace, K.A. Hartjes, M.C. Deeds, A.S. Armstrong, T. Thatava, T. Sakuma, A. Terzic, Y. Kudva, and Y. Ikeda Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency Aging (Albany, N.Y. Online) 4 2012 60 73
114. K. Oki, J. Tatarishvili, J. Wood, P. Koch, S. Wattananit, Y. Mine, E. Monni, D. Tornero, H. Ahlenius, and J. Ladewig Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain Stem Cells 30 2012 1120 1133
115. M.F. Oliver, and L.H. Opie Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias Lancet 343 1994 155 158
116. D. Onat, D. Brillon, P.C. Colombo, and A.M. Schmidt Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis Curr. Diab. Rep. 11 2011 193 202
117. K.K. Osbak, K. Colclough, C. Saint-Martin, N.L. Beer, C. Bellanné-Chantelot, S. Ellard, and A.L. Gloyn Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia Hum. Mutat. 30 2009 1512 1526
118. I.H. Park, N. Arora, H. Huo, N. Maherali, T. Ahfeldt, A. Shimamura, M.W. Lensch, C. Cowan, K. Hochedlinger, and G.Q. Daley Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
119. E.R. Pearson, G. Velho, P. Clark, A. Stride, M. Shepherd, T.M. Frayling, M.P. Bulman, S. Ellard, P. Froguel, and A.T. Hattersley beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations Diabetes 50 Suppl 1 2001 S101 S107
120. E.R. Pearson, I. Flechtner, P.R. Njølstad, M.T. Malecki, S.E. Flanagan, B. Larkin, F.M. Ashcroft, I. Klimes, E. Codner, V. Iotova Neonatal Diabetes International Collaborative Group Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations N. Engl. J. Med. 355 2006 467 477
121. G. Pellegrini, and M. De Luca Human embryonic stem cell-derived keratinocytes: how close to clinics? Cell Stem Cell 6 2010 8 9
122. K.F. Petersen, and G.I. Shulman Etiology of insulin resistance Am. J. Med. 119 Suppl 1 2006 S10 S16
123. N. Plengvidhya, S. Kooptiwut, N. Songtawee, A. Doi, H. Furuta, M. Nishi, K. Nanjo, W. Tantibhedhyangkul, W. Boonyasrisawat, and P.T. Yenchitsomanus PAX4 mutations in Thais with maturity onset diabetes of the young J. Clin. Endocrinol. Metab. 92 2007 2821 2826
124. J.M. Polo, S. Liu, M.E. Figueroa, W. Kulalert, S. Eminli, K.Y. Tan, E. Apostolou, M. Stadtfeld, Y. Li, and T. Shioda Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells Nat. Biotechnol. 28 2010 848 855
125. C. Polychronakos, and Q. Li Understanding type 1 diabetes through genetics: advances and prospects Nat. Rev. Genet. 12 2011 781 792
126. C.L. Prado, A.E. Pugh-Bernard, L. Elghazi, B. Sosa-Pineda, and L. Sussel Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development Proc. Natl. Acad. Sci. USA 101 2004 2924 2929
127. C. Pramfalk, E. Karlsson, L. Groop, L.L. Rudel, B. Angelin, M. Eriksson, and P. Parini Control of ACAT2 liver expression by HNF4alpha: lesson from MODY1 patients Arterioscler. Thromb. Vasc. Biol. 29 2009 1235 1241
128. H. Raeder, S. Johansson, P.I. Holm, I.S. Haldorsen, E. Mas, V. Sbarra, I. Nermoen, S.A. Eide, L. Grevle, and L. Bjørkhaug Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction Nat. Genet. 38 2006 54 62
129. C. Rask-Madsen, and C.R. Kahn Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease Arterioscler. Thromb. Vasc. Biol. 32 2012 2052 2059
130. A. Rezania, M.J. Riedel, R.D. Wideman, F. Karanu, Z. Ao, G.L. Warnock, and T.J. Kieffer Production of functional glucagon-secreting α-cells from human embryonic stem cells Diabetes 60 2011 239 247
131. R. Robinson, V.A. Barathi, S.S. Chaurasia, T.Y. Wong, and T.S. Kern Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals Dis. Model. Mech. 5 2012 444 456
132. D.A. Robinton, and G.Q. Daley The promise of induced pluripotent stem cells in research and therapy Nature 481 2012 295 305
133. T.J. Rowland, D.E. Buchholz, and D.O. Clegg Pluripotent human stem cells for the treatment of retinal disease J. Cell. Physiol. 227 2012 457 466
134. T.C. Schulz, H.Y. Young, A.D. Agulnick, M.J. Babin, E.E. Baetge, A.G. Bang, A. Bhoumik, I. Cepa, R.M. Cesario, and C. Haakmeester A scalable system for production of functional pancreatic progenitors from human embryonic stem cells PLoS ONE 7 2012 e37004
135. R.K. Semple, D.B. Savage, E.K. Cochran, P. Gorden, and S. O'Rahilly Genetic syndromes of severe insulin resistance Endocr. Rev. 32 2011 498 514
136. S. Shackleton, D.J. Lloyd, S.N. Jackson, R. Evans, M.F. Niermeijer, B.M. Singh, H. Schmidt, G. Brabant, S. Kumar, and P.N. Durrington LMNA, encoding lamin A/C, is mutated in partial lipodystrophy Nat. Genet. 24 2000 153 156
137. A.M. Shapiro State of the art of clinical islet transplantation and novel protocols of immunosuppression Curr. Diab. Rep. 11 2011 345 354
138. D.Q. Shih, H.M. Dansky, M. Fleisher, G. Assmann, S.S. Fajans, and M. Stoffel Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels Diabetes 49 2000 832 837
139. S. Shirasawa, S. Yoshie, F. Yue, H. Ichikawa, T. Yokoyama, M. Nagai, D. Tomotsune, M. Hirayama, and K. Sasaki Pancreatic exocrine enzyme-producing cell differentiation via embryoid bodies from human embryonic stem cells Biochem. Biophys. Res. Commun. 410 2011 608 613
140. S. Siegert, E. Cabuy, B.G. Scherf, H. Kohler, S. Panda, Y.Z. Le, H.J. Fehling, D. Gaidatzis, M.B. Stadler, and B. Roska Transcriptional code and disease map for adult retinal cell types Nat. Neurosci. 15 2012 487 495 S1-S2
141. C.Z. Song, G. Gavriilidis, H. Asano, and G. Stamatoyannopoulos Functional study of transcription factor KLF11 by targeted gene inactivation Blood Cells Mol. Dis. 34 2005 53 59
142. O. Søvik, P. Njølstad, I. Følling, J. Sagen, B.N. Cockburn, and G.I. Bell Hyperexcitability to sulphonylurea in MODY3 Diabetologia 41 1998 607 608
143. D.M. Sproule, and P. Kaufmann Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome Ann. N Y Acad. Sci. 1142 2008 133 158
144. A.K. Steck, and W.E. Winter Review on monogenic diabetes Curr. Opin. Endocrinol. Diabetes Obes. 18 2011 252 258
145. D.F. Steiner, H.S. Tager, S.J. Chan, K. Nanjo, T. Sanke, and A.H. Rubenstein Lessons learned from molecular biology of insulin-gene mutations Diabetes Care 13 1990 600 609
146. M. Stoffel, P. Froguel, J. Takeda, H. Zouali, N. Vionnet, S. Nishi, I.T. Weber, R.W. Harrison, S.J. Pilkis, and S. Lesage Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus Proc. Natl. Acad. Sci. USA 89 1992 7698 7702
147. D.A. Stoffers, N.T. Zinkin, V. Stanojevic, W.L. Clarke, and J.F. Habener Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence Nat. Genet. 15 1997 106 110
148. J. Støy, D.F. Steiner, S.Y. Park, H. Ye, L.H. Philipson, and G.I. Bell Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene Rev. Endocr. Metab. Disord. 11 2010 205 215
149. A. Swistowski, J. Peng, Q. Liu, P. Mali, M.S. Rao, L. Cheng, and X. Zeng Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions Stem Cells 28 2010 1893 1904
150. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
151. K.Y. Tan, S. Eminli, S. Hettmer, K. Hochedlinger, and A.J. Wagers Efficient generation of iPS cells from skeletal muscle stem cells PLoS ONE 6 2011 e26406
152. C.M. Taniguchi, B. Emanuelli, and C.R. Kahn Critical nodes in signalling pathways: insights into insulin action Nat. Rev. Mol. Cell Biol. 7 2006 85 96
153. S.I. Taylor Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene Diabetes 41 1992 1473 1490
154. A.K. Teo, R. Windmueller, B.B. Johansson, E. Dirice, P.R. Njolstad, E. Tjora, H. Raeder, and R.N. Kulkarni Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young J. Biol. Chem. 288 2013 5353 5356
155. G. Texido, I.H. Su, I. Mecklenbräuker, K. Saijo, S.N. Malek, S. Desiderio, K. Rajewsky, and A. Tarakhovsky The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation Mol. Cell. Biol. 20 2000 1227 1233
156. T. Thatava, Y.C. Kudva, R. Edukulla, K. Squillace, J.G. De Lamo, Y.K. Khan, T. Sakuma, S. Ohmine, A. Terzic, and Y. Ikeda Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells Mol. Ther. 21 2013 228 239
157. R.S. Tirabassi, J.F. Flanagan, T. Wu, E.H. Kislauskis, P.J. Birckbichler, and D.L. Guberski The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus ILAR J. 45 2004 292 302
158. G. Tiscornia, E.L. Vivas, and J.C. Izpisúa Belmonte Diseases in a dish: modeling human genetic disorders using induced pluripotent cells Nat. Med. 17 2011 1570 1576
159. C. Tsigos, I. Kyrou, and S.A. Raptis Monogenic forms of obesity and diabetes mellitus J. Pediatr. Endocrinol. Metab. 15 2002 241 253
160. V. Vallon, and S.C. Thomson Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney Annu. Rev. Physiol. 74 2012 351 375
161. T.L. van Belle, K.T. Coppieters, and M.G. von Herrath Type 1 diabetes: etiology, immunology, and therapeutic strategies Physiol. Rev. 91 2011 79 118
162. G. Velho, P. Froguel, K. Clement, M.E. Pueyo, B. Rakotoambinina, H. Zouali, P. Passa, D. Cohen, and J.J. Robert Primary pancreatic beta-cell
163. G. Velho, K.F. Petersen, G. Perseghin, J.H. Hwang, D.L. Rothman, M.E. Pueyo, G.W. Cline, P. Froguel, and G.I. Shulman Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects J. Clin. Invest. 98 1996 1755 1761
164. M. Vesterhus, H. Raeder, A.J. Kurpad, D. Kawamori, A. Molven, R.N. Kulkarni, C.R. Kahn, and P.R. Njølstad Pancreatic function in carboxyl-ester lipase knockout mice Pancreatology 10 2010 467 476
165. A.M. Vincent, B.C. Callaghan, A.L. Smith, and E.L. Feldman Diabetic neuropathy: cellular mechanisms as therapeutic targets Nat Rev Neurol 7 2011 573 583
166. P.M. Visscher, M.A. Brown, M.I. McCarthy, and J. Yang Five years of GWAS discovery Am. J. Hum. Genet. 90 2012 7 24
167. L. Wang, T.C. Schulz, E.S. Sherrer, D.S. Dauphin, S. Shin, A.M. Nelson, C.B. Ware, M. Zhan, C.Z. Song, and X. Chen Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling Blood 110 2007 4111 4119
168. M.J. Welham, M.P. Storm, E. Kingham, and H.K. Bone Phosphoinositide 3-kinases and regulation of embryonic stem cell fate Biochem. Soc. Trans. 35 2007 225 228
169. W.E. Winter, and D.A. Schatz Autoimmune markers in diabetes Clin. Chem. 57 2011 168 175
170. K.K. Wu, and Y. Huan Diabetic atherosclerosis mouse models Atherosclerosis 191 2007 241 249
171. K. Yamagata, H. Furuta, N. Oda, P.J. Kaisaki, S. Menzel, N.J. Cox, S.S. Fajans, S. Signorini, M. Stoffel, and G.I. Bell Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) Nature 384 1996 458 460
172. K. Yamagata, N. Oda, P.J. Kaisaki, S. Menzel, H. Furuta, M. Vaxillaire, L. Southam, R.D. Cox, G.M. Lathrop, and V.V. Boriraj Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature 384 1996 455 458
173. K. Yamagata, Q. Yang, K. Yamamoto, H. Iwahashi, J. Miyagawa, K. Okita, I. Yoshiuchi, J. Miyazaki, T. Noguchi, and H. Nakajima Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative Diabetes 47 1998 1231 1235
174. Y.M. Yang, S.K. Gupta, K.J. Kim, B.E. Powers, A. Cerqueira, B.J. Wainger, H.D. Ngo, K.A. Rosowski, P.A. Schein, and C.A. Ackeifi A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS Cell Stem Cell 12 2013 713 726
175. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, and R. Stewart Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
176. H. Zeng, M. Guo, K. Martins-Taylor, X. Wang, Z. Zhang, J.W. Park, S. Zhan, M.S. Kronenberg, A. Lichtler, and H.X. Liu Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells PLoS ONE 5 2010 e11853
177. T. Zhao, Z.N. Zhang, Z. Rong, and Y. Xu Immunogenicity of induced pluripotent stem cells Nature 474 2011 212 215
178. L. Zhou, W. Wang, Y. Liu, J. Fernandez de Castro, T. Ezashi, B.P. Telugu, R.M. Roberts, H.J. Kaplan, and D.C. Dean Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina Stem Cells 29 2011 972 980